Journal of Biotechnology and Biomedical Science
Aims & scope
JBBS publishes peer-reviewed research across biotechnology and biomedical science, from biological processes and molecular technologies to therapeutic development, bioengineering and translational applications.
- Applied biotechnology
- Biomedical science
- Reproducible methods
- Evidence-led claims
Initial fit check
- The biological system, material, assay or process is central to the study.
- The biotechnology or biomedical application is stated clearly.
- The methods, controls and evidence permit independent assessment.
- The conclusions do not extend beyond the data.
On this page
Scholarly purpose
The journal considers research across established and emerging areas of biotechnology and biomedical science. It welcomes fundamental, applied and translational work when the biological question, technical contribution and relevance to the field are clearly defined.
A manuscript should have a clear biological or biomedical question, reproducible methods and evidence that supports the claimed application. Novelty may lie in a process, material, assay, biological mechanism or analytical method; the work must still be sufficiently described and validated for another researcher to assess it.
Core scope
Research areas within scope
The following areas illustrate the journal’s remit. Interdisciplinary submissions are considered when they make a clear biotechnology or biomedical-science contribution.
Microbial and environmental biotechnology
Isolation, identification and screening of microorganisms; strain development; fermentation and bioprocess optimization; enzyme and metabolite production; biosorption, biodegradation and bioremediation; and water or environmental microbiology.
Required: organism, process, controls and measurable outcomeNatural-product and plant biotechnology
Phytochemical characterization; controlled antimicrobial or other bioactivity studies; plant cell and tissue culture; secondary-metabolite production; and crop biotechnology.
Required: identified material, appropriate controls and proportionate claimsBiomaterials and tissue engineering
Synthesis and physicochemical characterization of biomaterials; scaffold design; biological evaluation of materials intended for tissue or bone applications; and related bioengineering methods.
Required: material characterization and biological assessmentMolecular diagnostics and gene expression
Assay and method evaluation, biomarker measurement, gene-expression analysis, molecular genetic testing and diagnostic studies in defined samples or populations. Negative and confirmatory findings may be suitable.
Required: comparator, performance measures and stated limitationsMedical and pharmaceutical biotechnology
Biotechnology approaches to therapeutic development, pharmaceutical production, drug discovery, formulation and delivery, pharmacogenomics and related biomedical applications.
Required: defined biological rationale, appropriate controls and translational relevanceCell and gene therapy, vaccines and immunotechnology
Cellular therapies, gene editing and delivery, vaccine design and evaluation, immune-engineering methods and immunotechnology platforms.
Required: biological validation, safety considerations and proportionate claimsSynthetic and systems biology
Engineered biological systems, metabolic and pathway engineering, systems-level analysis, functional genomics, proteomics, metabolomics and reproducible bioinformatics.
Required: transparent data, reproducible analysis and experimental or independent validationRegenerative medicine and translational biomedicine
Regenerative strategies, tissue repair, disease models, translational biomedical research and preclinical evaluation of biological technologies.
Required: defined clinical or biological relevance and an appropriate evidence pathwayBiomanufacturing and industrial biotechnology
Bioprocess design, scale-up, process control, biological production systems, downstream processing and sustainable industrial biotechnology.
Required: process definition, performance measures and reproducible operating conditionsBiomedical engineering, biosensors and imaging
Bioinstrumentation, biosensors, biomedical imaging, diagnostic devices, computational biomedicine and integrated biological or clinical measurement platforms.
Required: technical characterization, biological validation and an appropriate comparatorThe common rule across all four domains
Scientific fit
The study develops, characterizes or evaluates a biological process, product, material, assay or biomedical method.
Evidence fit
The methods, controls, validation and primary data are sufficient to test the central claim.
Interdisciplinary work
When an adjacent subject fits
Work at the boundary of biotechnology, engineering and medicine is considered by contribution, not by label. Borderline manuscripts should explain what is technically new, how it was validated and why the result matters to biotechnology or biomedical science.
- Biomedical engineering, biosensors, imaging and analytical platformsSuitable when a biological or biomedical use is defined and performance is validated against an appropriate comparator.
- Genomics, proteomics, bioinformatics and computational methodsSuitable when the work answers a defined biological question, identifies the data and validation set, and provides a reproducible analysis. An unvalidated algorithm or database exercise is not enough.
- Drug delivery, nanobiotechnology and preclinical platformsSuitable when the primary contribution is the carrier, material, delivery system or biological mechanism. A routine treatment-effect study is not enough.
- Translational and clinical researchSuitable when a biotechnology, biomarker, assay, material or imaging method is the principal contribution. Patient outcomes alone are outside scope.
- Agricultural, food, industrial and environmental workSuitable when it develops or evaluates a biological process, organism, product or biotechnology method. A general agronomic or environmental survey is not enough.
- Animal or cell-based studiesSuitable when they evaluate a biotechnology or biomedical mechanism or platform with appropriate ethics, identity, controls and reproducibility.
Scope boundaries
What the journal does not consider
JBBS is not a general clinical, public-health, engineering, chemistry or life-science journal. A manuscript is outside scope when its primary contribution cannot be assessed as biotechnology or biomedical science.
These criteria govern new submissions. The archive also contains articles outside the journal’s current priorities; an earlier publication does not by itself establish present scope.
- Clinical treatment, patient-care, surgical or public-health studies without a biotechnology, biomarker, material, assay or validated biomedical-method contribution.
- Epidemiological, behavioral, occupational-health, nursing or education studies without a biotechnology or biomedical-science question.
- Routine prevalence, correlation or diagnostic studies using established tests without a methodological, molecular or biomarker contribution.
- Purely theoretical, computational or device-engineering work without biological data or biological validation.
- Generic pharmacology, toxicology or animal treatment studies that do not develop or test a biotechnology or biomedical platform.
- Descriptive plant extracts, essential oils or natural products without adequate identification, controls and reproducible biological evaluation.
- Fundamental molecular or cellular studies with no clear biotechnology or biomedical relevance.
- Claims that lack a plausible, testable biological rationale, validated methods or evidence sufficient for independent assessment and replication.
- Manuscripts whose methods, primary data, material identity or ethics documentation are insufficient for independent assessment.
Assessment standard
Evidence expected in an in-scope paper
Scope fit does not replace scientific and research-integrity assessment. Authors should provide the information needed to evaluate the material, method and claim.
| Evidence area | What the manuscript should make assessable |
|---|---|
| Materials | Identity and provenance of strains, cell lines, plant material, reagents, constructs, specimens and samples. |
| Study design | Appropriate controls, biological and technical replication, clearly stated comparisons, prespecified where applicable, and statistical methods. |
| Validation | An appropriate comparator or independent dataset where the claim concerns a method, assay, biomarker, material or model. |
| Ethics and safety | Ethics, consent, animal-welfare and biosafety documentation where the work requires it. |
| Reproducibility | Data, code, repository records or accession information sufficient to assess and reproduce the work. |
| Figures and images | Processing that preserves the underlying evidence and permits the reported result to be checked. |
Detailed requirements are set out in the Instructions for Authors and Editorial Policies.
Publication formats
Article types currently accepted by JBBS
JBBS currently accepts Research Articles, Review Articles and Short Communications. Legacy archive records labeled “In Brief” are historical publications in the concise-report category.
Research Article
A full report of original experimental, analytical, computational or method-evaluation research within the journal’s scope.
Review Article
A critical synthesis of a defined biotechnology or biomedical-science question that states how the literature was identified and assessed.
Short Communication
A concise report of a focused result or analysis that can be evaluated from complete methods and supporting evidence.
Authors proposing another format should contact the editorial office before preparing a submission. A format not listed here should not be assumed to be accepted.
Community
Who writes for and reads JBBS
Intended authors
Biotechnologists, biomedical scientists, molecular and cellular biologists, geneticists, immunologists, pharmacologists, bioengineers, biomaterials and regenerative-medicine researchers, bioprocess specialists, bioinformaticians, diagnostic and imaging researchers, and translational investigators.
Intended readers
Laboratory scientists, clinicians, engineers, method developers and biomedical researchers assessing biological mechanisms, technologies, materials, therapies and translational applications.
Before submission
Authors should be able to answer yes to each point below before proceeding.
- The manuscript fits a stated scope area, or makes a clear interdisciplinary biotechnology or biomedical-science contribution.
- The biological or biomedical contribution is explicit and not inferred from keywords alone.
- The material, assay, process or model is identified and the method can be assessed.
- The controls, validation and statistical approach match the claim.
- Required ethics, consent, welfare, biosafety and data information is available.
If fit remains uncertain after reading this page, send the title and abstract to info@openaccesspub.org before submitting. The editorial office may advise on scope, but that advice is not an acceptance decision and does not bypass peer review.
Prepare the manuscript against the journal requirements
Read the author instructions before submission; they set out the manuscript files, declarations and reporting information the editorial office needs.
This page defines scholarly fit. Peer-review, research-integrity, data and ethics requirements remain independently applicable to every manuscript within scope. The archive shows the journal’s published record.